/WHWK
WHWK Stock - Whitehawk Therapeutics Inc
Healthcare|BiotechnologyNASDAQ
$2.56+5.79%
+$0.14 (+5.79%) • Dec 19
77
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.97
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.92
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.82
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for WHWK
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.53 – $2.59
TARGET (TP)$2.94
STOP LOSS$2.36
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.69
52W High$3.81
52W Low$1.39
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $25.98M | $24.35M | $15.22M | $1.12M | $14.58M |
| Gross Profit | $-28,071,000 | $-27,384,000 | $-18,781,000 | $-18,550,000 | $-428,000 |
| Gross Margin | -108.0% | -112.4% | -123.4% | -1656.3% | -2.9% |
| Operating Income | $-67,458,000 | $-71,933,000 | $-62,681,000 | $-111,217,000 | $-2,549,000 |
| Net Income | $-63,691,000 | $-65,765,000 | $-60,513,000 | $-110,090,000 | $-3,478,000 |
| Net Margin | -245.1% | -270.0% | -397.7% | -9829.5% | -23.9% |
| EPS | $-2.36 | $-2.44 | $-2.69 | $-12.41 | $-0.21 |
Company Overview
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
WHWKBeat Rate
50%
Last 4 quarters
Avg Surprise
-97.2%
EPS vs Estimate
Beats / Misses
2/2
Last 12 quarters
Latest EPS
$-0.26
Q4 2025
EPS Surprise History
Q1 25
-204.5%
$-0.67vs$-0.22
Q2 25
+21.7%
$-0.36vs$-0.46
Q3 25
-255.1%
$-0.76vs$0.49
Q4 25
+49.0%
$-0.26vs$-0.51
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 17, 2026 | $-0.69 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.51 | $-0.26 | +49.0% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.49 | $-0.76 | -255.1% | ✗ MISS |
Q2 2025 | May 8, 2025 | $-0.46 | $-0.36 | +21.7% | ✓ BEAT |
Q1 2025 | Mar 18, 2025 | $-0.22 | $-0.67 | -204.5% | ✗ MISS |
Latest News
Whitehawk Therapeutics Q3 EPS $(0.26) Misses $0.07 Estimate
📉 NegativeBenzinga•Nov 6, 2025, 01:37 PM
Whitehawk Therapeutics Presents Data From Protein Tyrosine Kinase 7 Analysis From Over 157K Tumor Samples At 2025 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
➖ NeutralBenzinga•Oct 24, 2025, 04:34 PM
Whitehawk Therapeutics shares are trading higher after the company announced a multi-year collaboration with Tempus AI to leverage Tempus' proprietary real-world dataset to advance biomarker-driven research and support the development of Whitehawk Therapeutics' oncology pipeline.
📈 PositiveBenzinga•Oct 16, 2025, 12:52 PM•Also:
Tempus AI Enters A Multi-Year Collaboration With Whitehawk Therapeutics To Leverage Tempus' Real-World Data And AI Capabilities For Biomarker-Driven Cancer Research
📈 PositiveBenzinga•Oct 16, 2025, 12:32 PM•Also:
Frequently Asked Questions about WHWK
What is WHWK's current stock price?
Whitehawk Therapeutics Inc (WHWK) is currently trading at $2.56 per share. The stock has moved +5.79% today.
What is the analyst price target for WHWK?
No analyst price targets are currently available for this stock.
What sector is Whitehawk Therapeutics Inc in?
Whitehawk Therapeutics Inc operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is WHWK's market cap?
Whitehawk Therapeutics Inc has a market capitalization of $0.12 billion, making it a small-cap company.
Does WHWK pay dividends?
No, Whitehawk Therapeutics Inc does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATOS
Atossa Therapeutics, Inc.
$0.73
Mkt Cap: $0.1B
CLNN
Clene Inc.
$6.68
Mkt Cap: $0.1B
CNTX
Context Therapeutics Inc.
$1.27
Mkt Cap: $0.1B
IMMX
Immix Biopharma, Inc.
$5.72
Mkt Cap: $0.2B
MGNX
MacroGenics, Inc.
$1.50
Mkt Cap: $0.1B
ONCY
Oncolytics Biotech Inc.
$1.01
Mkt Cap: $0.1B
OVID
Ovid Therapeutics Inc.
$1.47
Mkt Cap: $0.1B
PLRX
Pliant Therapeutics, Inc.
$1.23
Mkt Cap: $0.1B
TVGN
Tevogen Bio Holdings Inc.
$0.38
Mkt Cap: $0.1B
ZNTL
Zentalis Pharmaceuticals, Inc.
$1.40
Mkt Cap: $0.1B
Explore stocks similar to WHWK for comparison